RBD1016-a novel anti-HBV GalNAc-siRNA drug resulted in sustained HBsAg reduction and seroconversion in mice modelsLi Ming Gan,Shuquan Zheng, Feng Li,Zhaoxu Guo, Hong Yu,Hongyan Zhang,Zicai Liang,Shan GaoJOURNAL OF HEPATOLOGY（2023）引用 1|浏览4暂无评分关键词sustained hbsag reduction,anti-hbv,galnac-sirnaAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
